{"status": "OK", "response": {"docs": [{"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "Public health officials have recommended a new, shorter course of chemotherapy for tuberculosis that combines the use of two drugs instead of one and promises to cut the traditional 18-month treatment for the disease by half.", "headline": {"main": "NEW TB TREATMENT GETS BACKING IN U.S.; Public Health Groups Recommend Combined Use of Two Drugs to Shorten Therapy Time Number of Cases Has Diminished 'Striking Potency' Some Abandon Treatment"}, "abstract": "Public health officials recommend new, shorter course of chemotherapy for tuberculosis that combines use of drugs isoniazid and rifampin and cuts traditional 18-month treatment for disease by half; shorter therapy is based on series of clinical studies by British Medical Research Council during last 10 years; Drs Laurence S Farer (Center for Disease Control), Michael D Iseman (American Thoracic Society committee chmn) and Alje Vennema (NYC Health Dept) comment (M)", "print_page": "19", "word_count": 819, "_id": "4fc4a39b45c1498b0dab02ff", "snippet": "Public health officials have recommended a new, shorter course of chemotherapy for tuberculosis that combines the use of two drugs instead of one and promises to cut the traditional 18-month treatment for the disease by half.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9A02E1DD1639E731A2575AC0A9659C94619FD6CF", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "TUBERCULOSIS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Ronald", "rank": 1, "lastname": "SULLIVAN"}], "original": "By RONALD SULLIVAN"}, "document_type": "article", "pub_date": "1980-03-09T00:00:00Z", "section_name": null}], "meta": {"hits": 1, "offset": 0, "time": 51}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}